Open AccessBook
Evaluation and monitoring of screening programmes
About:
The article was published on 2001-01-01 and is currently open access. It has received 56 citations till now.read more
Citations
More filters
Journal ArticleDOI
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco,Joakim Dillner,K. Miriam Elfström,Sara Tunesi,Peter J.F. Snijders,Marc Arbyn,Henry C Kitchener,Nereo Segnan,Clare Gilham,Paolo Giorgi-Rossi,Johannes Berkhof,Julian Peto,Chris J.L.M. Meijer +12 more
TL;DR: Data of large-scale randomised trials support initiation of HPV-based screening from age 30 years and extension of screening intervals to at least 5 years, and provide 60-70% greater protection against invasive cervical carcinomas compared with cytology.
Journal ArticleDOI
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco,Paolo Giorgi-Rossi,Francesca Carozzi,Massimo Confortini,Paolo Palma,Annarosa Del Mistro,B. Ghiringhello,Salvatore Girlando,Anna Gillio-Tos,Laura De Marco,Carlo Naldoni,Paola Pierotti,Raffaella Rizzolo,Patrizia Schincaglia,Manuel Zorzi,Marco Zappa,Nereo Segnan,Jack Cuzick +17 more
TL;DR: HPV-based screening is more effective than cytology in preventing invasive cervical cancer, by detecting persistent high-grade lesions earlier and providing a longer low-risk period, but in younger women, HPV screening leads to over-diagnosis of regressive CIN2.
Journal ArticleDOI
Neuroblastoma screening at one year of age
Freimut H. Schilling,Claudia Spix,Frank Berthold,Rudolf Erttmann,N. Fehse,Barbara Hero,Gisela Klein,Johannes Sander,Kerstin Schwarz,Joern Treuner,Ulrich Zorn,Joerg Michaelis +11 more
TL;DR: The present findings do not support the usefulness of general screening for neuroblastoma at one year of age and reveal substantial overdiagnosis in the former group.
Journal ArticleDOI
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
Freddie Bray,Bendix Carstensen,Henrik Møller,Marco Zappa,Maja Primic Zakelj,Gill Lawrence,Matti Hakama,Elisabete Weiderpass +7 more
TL;DR: Whereas increasing specificity of subtype with time may be responsible for some of the increases in several countries, the changing distribution and prevalence of persistent infection with high-risk human papillomavirus types, alongside an inability to detect cervical adenocarcinoma within screening programs, would accord with the temporal profile observed in Europe.
Journal ArticleDOI
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.
Cheng Har Yip,Robert A. Smith,Benjamin O. Anderson,Benjamin O. Anderson,Anthony B. Miller,David B. Thomas,Eng Suan Ang,Rosemary S. Caffarella,Marilys Corbex,Gary L. Kreps,Anne McTiernan +10 more
TL;DR: The effectiveness and efficiency of screening modalities, including screening mammography, clinical breast examination (CBE), and breast self‐examination, were reviewed in the context of resource availability and population‐based need by the panel.
References
More filters
Journal ArticleDOI
Trends in mortality from cervical cancer in the nordic countries: association with organised screening programmes
TL;DR: Investigation of time trends in mortality from cervical cancer in Denmark, Finland, Iceland, Norway, and Sweden since the early 1950s supports the conclusion that organised screening programmes have had a major impact on the reduction in mortality in the Nordic countries.
Journal ArticleDOI
Multistage Models and Primary Prevention of Cancer
Nicholas E. Day,Charles C. Brown +1 more
TL;DR: The long-term danger arising from entry into the environment of early-stage carcinogens is discussed, and it is shown that by the time human evidence that a hazard does exist becomes available, those already exposed may well have accumulated their fully effective doses.
Journal ArticleDOI
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study
TL;DR: A breast screening programme can achieve a similar effect on mortality as achieved by the trials for breast cancer screening, but it may be difficult to justify a screening programme as a public health policy on the basis of the mortality reduction only.
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
TL;DR: Time trends and differentials in cancer incidence in the five Nordic countries, Denmark, Finland, Iceland, Norway and Sweden, were investigated, using material collected by the cancer registries in each country by age, birth cohort and time period.